tert-Butyl (8-iodo-2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-6-yl)carbamate

Catalog No.: 
ACFOET901
CAS No.: 
1823254-93-8
Molecular Formula: 
C13H15IN2O4
Molecular Weight: 
390.18
tert-Butyl (8-iodo-2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-6-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1053.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (8-iodo-2-oxo-2,4-dihydro-1H-benzo[d][1,3]oxazin-6-yl)carbamate
IUPAC Nametert-butyl (8-iodo-2-oxo-1,4-dihydro-2H-benzo[d][1,3]oxazin-6-yl)carbamate
MDL No.MFCD23703460
Molecular FormulaC13H15IN2O4
Molecular Weight390.18
SMILESO=C(OC(C)(C)C)NC1=CC(I)=C2NC(OCC2=C1)=O
InChI KeyKVMBRNWFPWHJKZ-UHFFFAOYSA-N
SynonymTERT-BUTYL (8-IODO-2-OXO-2,4-DIHYDRO-1H-BENZO[D][1,3]OXAZIN-6-YL)CARBAMATE;Carbamic acid, N-(1,4-dihydro-8-iodo-2-oxo-2H-3,1-benzoxazin-6-yl)-, 1,1-dimethylethyl ester
CAS No.1823254-93-8

Synthetic Route by SureRoute

1. ACFOET901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHQO530 route compound structure diagram
    ACEHQO5304248-19-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFOET901 route product structure diagram
    ACFOET9011823254-93-8
Inquiry

2. ACFOET901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHQO530 route compound structure diagram
    ACEHQO5304248-19-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFOET901 route product structure diagram
    ACFOET9011823254-93-8
Inquiry

3. ACFOET901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFOET901 route product structure diagram
    ACFOET9011823254-93-8
Inquiry

Comments (0)